SOPH logo

SOPH
SOPHiA Genetics SA

252
Mkt Cap
$361.21M
Volume
83,449.00
52W High
$5.70
52W Low
$2.58
PE Ratio
-4.31
SOPH Fundamentals
Price
$5.04
Prev Close
$5.09
Open
$5.05
50D MA
$4.82
Beta
0.94
Avg. Volume
110,851.50
EPS (Annual)
-$1.17
P/B
7.32
Rev/Employee
$186,195.18
$308.14
Loading...
Loading...
News
all
press releases
SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $21,398.22 in Stock
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) CEO Jurgi Camblong sold 4,486 shares of SOPHiA GENETICS stock in a transaction on Thursday, March 19th. The stock was sold at an average price of $4.77, for a total transaction of $21,398.22. Following the transaction, the chief executive officer...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,486 Shares
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) CEO Jurgi Camblong sold 4,486 shares of the stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $4.77, for a total value of $21,398.22. Following the sale, the chief executive officer directly...
MarketBeat·16d ago
News Placeholder
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 182,807...
MarketBeat·21d ago
News Placeholder
SOPHiA GENETICS Q4 Earnings Call Highlights
SOPHiA GENETICS (NASDAQ:SOPH) executives highlighted accelerating commercial momentum, expanding platform capabilities, and improved profitability outlook during the company's fourth-quarter and...
MarketBeat·1mo ago
News Placeholder
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·1mo ago
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS
SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.20) by...
MarketBeat·1mo ago
News Placeholder
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results PR Newswire BOSTON and ROLLE, Switzerland, March 3, 2026 BOSTON...
PR Newswire·1mo ago
News Placeholder
A Look at Sophia Genetics's Upcoming Earnings Report
read more...
Benzinga·1mo ago
News Placeholder
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference PR Newswire BOSTON and ROLLE, Switzerland...
PR Newswire·1mo ago
News Placeholder
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
TEM heads into Q4 earnings with expected 82.8% revenue growth, rising oncology momentum and a premium valuation clouding near-term upside.
Zacks·2mo ago
<
1
2
...
>

Latest SOPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.